 Flecainide
"Flecainide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
| Descriptor ID |
D005424
|
| MeSH Number(s) |
D03.383.621.270
|
| Concept/Terms |
Tambocor- Tambocor
- United Drug Brand of Flecainide Acetate
- Flécaïne
- Riker Brand of Flecainide Acetate
- 3M Brand of Flecainide Acetate
- Apocard
Flecadura- Flecadura
- Merck dura Brand of Flecainide Acetate
Flecainid-Isis- Flecainid-Isis
- Flecainid Isis
- Alpharma Brand of Flecainide Acetate
Flecatab- Flecatab
- Alphapharm Brand of Flecainide Acetate
|
Below are MeSH descriptors whose meaning is more general than "Flecainide".
Below are MeSH descriptors whose meaning is more specific than "Flecainide".
This graph shows the total number of publications written about "Flecainide" by people in this website by year, and whether "Flecainide" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1984 | 0 | 2 | 2 | | 1985 | 0 | 2 | 2 | | 1986 | 0 | 3 | 3 | | 1987 | 1 | 0 | 1 | | 1991 | 1 | 0 | 1 | | 1993 | 0 | 1 | 1 | | 1994 | 0 | 1 | 1 | | 2008 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Flecainide" by people in Profiles.
-
Somberg JC. Flecainide: safety and efficacy. Cardiology. 2008; 111(2):82.
-
Peters RW, Mitchell LB, Brooks MM, Echt DS, Barker AH, Capone R, Liebson PR, Greene HL. Circadian pattern of arrhythmic death in patients receiving encainide, flecainide or moricizine in the Cardiac Arrhythmia Suppression Trial (CAST). J Am Coll Cardiol. 1994 Feb; 23(2):283-9.
-
Epstein AE, Hallstrom AP, Rogers WJ, Liebson PR, Seals AA, Anderson JL, Cohen JD, Capone RJ, Wyse DG. Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction. The original design concept of the Cardiac Arrhythmia Suppression Trial (CAST). JAMA. 1993 Nov 24; 270(20):2451-5.
-
Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med. 1991 Mar 21; 324(12):781-8.
-
Somberg JC, Tepper D, Sacher H, Schwarz J. Chronic flecainide therapy selected by electrophysiology testing of intravenous flecainide. Am Heart J. 1987 Jul; 114(1 Pt 1):18-25.
-
Wynn J, Fingerhood M, Keefe D, Maza S, Miura D, Somberg JC. Refractory ventricular tachycardia with flecainide. Am Heart J. 1986 Jul; 112(1):174-5.
-
Somberg JC, Miura D, Keefe DL. The treatment of ventricular rhythm disturbances. Am Heart J. 1986 Jun; 111(6):1162-76.
-
Wynn J, Torres V, Flowers D, Mizruchi M, Keefe D, Miura D, Somberg J. Antiarrhythmic drug efficacy at electrophysiology testing: predictive effectiveness of procainamide and flecainide. Am Heart J. 1986 Apr; 111(4):632-8.
-
Somberg J. Antiarrhythmic drug therapy. Recent advances and current status. Cardiology. 1985; 72(5-6):329-48.
-
Flowers D, O'Gallagher D, Torres V, Miura D, Somberg JC. Flecainide: long-term treatment using a reduced dosing schedule. Am J Cardiol. 1985 Jan 01; 55(1):79-83.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|